CME vs MSCI

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Jul 22, 2026

CME

50.2
AI Score
VS
CME Wins

MSCI

47.1
AI Score

Investment Advisor Scores

CME

50score
Recommendation
HOLD

MSCI

47score
Recommendation
HOLD

AI Analyst Insights

Detailed Metrics Comparison

Metric CME MSCI Winner
Forward P/E 20.0401 31.9489 CME
PEG Ratio 4.3015 2.0238 MSCI
Revenue Growth 14.4% 14.1% CME
Earnings Growth 21.3% 49.1% MSCI
Tradestie Score 50.2/100 47.1/100 CME
Profit Margin 63.3% 40.7% CME
Beta 1.00 1.00 Tie
AI Recommendation HOLD HOLD Tie

Frequently Asked Questions

Based on our detailed analysis, CME is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.